Needham & Company LLC reaffirmed their buy rating on shares of Azenta (NASDAQ:AZTA – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $75.00 price target on the stock.
AZTA has been the subject of a number of other research reports. Stephens reiterated an equal weight rating and set a $70.00 price target on shares of Azenta in a research report on Thursday, February 8th. Jefferies Financial Group initiated coverage on Azenta in a report on Thursday, April 4th. They issued a hold rating and a $64.00 price objective for the company. Evercore ISI cut their price objective on Azenta from $64.00 to $60.00 and set an in-line rating for the company in a report on Thursday, April 4th. Finally, B. Riley upped their price objective on Azenta from $61.00 to $79.00 and gave the company a buy rating in a report on Thursday, February 1st. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of Hold and an average price target of $69.60.
View Our Latest Stock Analysis on AZTA
Azenta Stock Performance
Azenta (NASDAQ:AZTA – Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The company had revenue of $154.32 million during the quarter, compared to analyst estimates of $151.86 million. Equities research analysts predict that Azenta will post 0.27 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Azenta
Hedge funds have recently modified their holdings of the stock. TFC Financial Management Inc. purchased a new stake in shares of Azenta during the third quarter valued at $25,000. Headlands Technologies LLC purchased a new stake in shares of Azenta during the third quarter valued at $33,000. Principal Securities Inc. purchased a new stake in shares of Azenta during the fourth quarter valued at $36,000. Northwest Financial Advisors purchased a new stake in shares of Azenta during the fourth quarter valued at $46,000. Finally, Point72 Europe London LLP acquired a new position in Azenta during the fourth quarter valued at $48,000. 99.08% of the stock is owned by hedge funds and other institutional investors.
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
- Five stocks we like better than Azenta
- What Makes a Stock a Good Dividend Stock?
- Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
- Insider Trading – What You Need to Know
- WD-40 Company Greases the Wheels of Growth and Profits
- 3 Tickers Leading a Meme Stock Revival
- How to Protect your Portfolio Against a Rising VIX
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.